Claire F Verschraegen (Claire Verschraegen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO oncology practice

Future oncology (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

The Ohio State University Comprehensive Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Ohio State University Comprehensive Cancer Center Jun 01 2017

United States

Director, Division of Medical Oncology :: Internal Medicine - Medical Oncology

Publications

Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I study of SYNB1891, an engineered E coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
P Abena Anyidoho, Claire F Verschraegen, Merry-Jennifer Markham, Steven R Alberts, John Sweetenham, Kendra Cameron, Taher Abu Hejleh
Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer. JCO oncology practice (2023)
Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, David R Spigel, Howard Safran, Matthew H Taylor, Jaafar Bennouna, Deborah J Wong, Karen Kelly, Claire F Verschraegen, Marcis Bajars, Juliane Manitz, Mary Ruisi, James L Gulley
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor. Future oncology (London, England) 18 (11) (2022)
Dwight H Owen, Brooke Benner, Lai Wei, Vineeth K Sukrithan, Ashima Goyal, Ye Zhou, Carly Pilcher, Sheryl-Ann Suffren, Gwen Christenson, Nancy Curtis, Megan Jukich, Emily Schwarz, Himanshu Savardekar, Ruthann Norman, Sarah Ferguson, Barbara Kleiber, Robert Wesolowski, William E Carson, Gregory A Otterson, Claire F Verschraegen, Manisha H Shah, Bhavana Konda
A phase 2 clinical trial of nivolumab and temozolomide for neuroendocrine neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Claire F Verschraegen, Guy Jerusalem, Edward F McClay, Nicholas Iannotti, Charles H Redfern, Jaafar Bennouna, Franklin L Chen, Karen Kelly, Janice Mehnert, John C Morris, Matthew Taylor, David Spigel, Ding Wang, Hans Juergen Grote, Dongli Zhou, Neru Munshi, Marcis Bajars, James L Gulley
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Journal for immunotherapy of cancer 8 (2) (2021)
Sant P Chawla, Brian Andrew Van Tine, Seth M Pollack, Kristen N Ganjoo, Anthony D Elias, Richard F Riedel, Steven Attia, Edwin Choy, Scott H Okuno, Mark Agulnik, Margaret von Mehren, Michael B Livingston, Vicki L Keedy, Claire F Verschraegen, Tony Philip, G Chet Bohac, Sergey Yurasov, Adam Yakovich, Hailing Lu, Michael Chen, Robert G Maki
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Lowell Anthony, George Atweh, Ravi Bhatia, Lisa Anne Carey, Jenny C Chang, Martin J Edelman, Philip W Kantoff, Merry-Jennifer Markham, Wells Messersmith, Edward L Nelson, Kurt Oettel, Ruth O'Regan, Claire F Verschraegen, Julie M Vose
Benchmarks for Academic Oncology Faculty. JCO oncology practice 17 (3) (2020)

Claire F Verschraegen.css-eqlu8i{font-size:small;padding-left:4px;} (Claire Verschraegen)

Publication Activity (10 Years)

Top Topics

Top Venues

Claire F Verschraegen (Claire Verschraegen)